0R2M Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 632.5 USD 0.98% Market Closed

Market Cap: $66.5B

	Regeneron Pharmaceuticals Inc LSE:0R2M	US
F	Fluor Corp XBER:FLU	US
B	British American Tobacco PLC F:BMTA	UK
S	Sysco Corp BMV:SYY	US
S	Saul Centers Inc F:SA4	US
C	Cigna Corp XETRA:CGN	US
	Home Depot Inc NYSE:HD	US
H	Huntington Bancshares Inc XMUN:HU3	US
R	Rigel Pharmaceuticals Inc F:RI2A	US
	Cerence Inc NASDAQ:CRNC	US

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

89% > 87%

Healthy Operating Margin

27%

Strong 3Y Average Operating Margin

31%

Declining Operating Margin

40% > 27%

Exceptional Net Margin

31%

Strong 3Y Average Net Margin

32%

Declining Net Margin

34% > 31%

Exceptional Free Cash Flow Margin

26%

Strong 3Y Average Free Cash Flow Margin

26%

Free Cash Flow Margin is Increasing

20% > 26%

Positive ROE

15%

Positive 3Y Average ROE

Positive 3Y Average ROIC

17%

Declining ROIC

22% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.